Guilford, CT, United States of America

Wallace C Pringle

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
7 patents (USPTO):

Title: Wallace C. Pringle: Innovator in Pharmaceutical Chemistry

Introduction

Wallace C. Pringle is a notable inventor based in Guilford, CT, who has made significant contributions to the field of pharmaceutical chemistry. With a total of seven patents to his name, Pringle's work focuses on developing compounds that have the potential to treat various central nervous system disorders.

Latest Patents

Pringle's latest patents include innovative compounds such as thiazole amides and imidazole amides. These compounds are designed to modulate ligand binding to histamine H3 receptors, which can be beneficial in treating a range of CNS disorders in humans and animals. Additionally, he has developed substituted 1-benzyl-4-substituted piperazine analogues that target MCH receptors, offering potential treatments for metabolic, feeding, and sexual disorders.

Career Highlights

Pringle is associated with Neurogen Corporation, where he has been instrumental in advancing research and development in pharmaceutical applications. His expertise in creating effective compounds has positioned him as a key figure in the industry.

Collaborations

Some of his notable coworkers include Alan J. Hutchison and John M. Peterson, who have collaborated with him on various projects within the company.

Conclusion

Wallace C. Pringle's innovative work in pharmaceutical chemistry continues to pave the way for new treatments for CNS and metabolic disorders. His contributions are invaluable to the field and highlight the importance of research in developing effective medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…